What You Should Know:
– ConcertAI, the leader in predictive and generative AI SaaS and DaaS Solutions for healthcare and life sciences, today announced a Software-as-a-Service (SaaS) cloud version of TeraRecon’s AI-enabled portfolio of advanced visualization (AV) and generative AI modules for clinical workflows.
– This is a milestone in making the best-in-class solution more accessible to healthcare providers, and brings together Intuition Advanced Visualization, Eureka Clinical AI, and CARAai™ in one cloud platform. This addition of the SaaS platform allows healthcare organizations to utilize the latest TeraRecon solutions in different configurations at the enterprise and network levels and assures consistency in AI enabled-workflows everywhere.
ConcertAI Advances Healthcare with Predictive and Generative AI SaaS Solutions via TeraRecon Cloud Platform
ConcertAI, a leader in predictive and generative AI SaaS solutions, delivers real-world data research for healthcare and life sciences. Its mission is to enhance patient outcomes by combining research-ready data, CARA™ AI technologies, and scientific expertise in collaboration with 46+ biomedical innovators, 2,000 healthcare providers, and medical societies.
TeraRecon’s advanced visualization (AV) capabilities are now fully cloud-enabled, offering healthcare organizations subscription-based access to AI-driven clinical tools. This cloud-based model eliminates the need for on-premises infrastructure and aligns with the global shift toward cloud adoption, with over 65% of healthcare organizations already leveraging cloud solutions for core clinical applications. The cloud SaaS model provides the following benefits:
– Immediate Access: Subscribers gain continuous access to cutting-edge AI-enabled tools and workflows.
– Scalability and Flexibility: Infrastructure is adaptable to various IT environments across healthcare providers and partners.
– Enhanced Compliance: Automatic software updates and security patches ensure adherence to standards like HIPAA, GDPR, and SOC2.
– Cost Efficiency: The subscription model reduces total ownership costs and ensures future compatibility with emerging technologies.
The latest additions to the TeraRecon portfolio include the Intuition 4.10 software, featuring 200+ physician-informed enhancements, and the FDA-cleared AI-driven auto-contouring algorithm for cardiac MR. These innovations reflect ConcertAI’s commitment to meaningful advancements in clinical practice.
Attendees at RSNA 2024 can explore TeraRecon’s Intuition platform and other innovations at Booth #8134, North Hall, McCormick Place, Chicago. The exhibit includes interactive demonstrations, while engaging customer events foster peer-to-peer learning and hands-on experiences. Interested parties can schedule a meeting through TeraRecon’s website.
“ConcertAI is focused on delivering leading-in-class AI SaaS solutions for healthcare’s most time-critical and acute decisions,” said Jeff Elton, PhD, CEO of ConcertAI. “With the broadest multi-modal Data-as-a-Service and leading CARAai™ AI SaaS solutions, we are supporting thousands of clinicians in their diagnosis and treatment decisions for tens of thousands of patients every day. With this combination of cloud and AI SaaS, TeraRecon solutions can assure the productivity of radiological teams globally, timely and accurate diagnoses, and cross-discipline collaboration and care coordination.”
